Literature DB >> 7715339

Is lung cancer associated with asbestos exposure when there are no small opacities on the chest radiograph?

P Wilkinson1, D M Hansell, J Janssens, M Rubens, R M Rudd, A N Taylor, C McDonald.   

Abstract

This study was designed to test the hypothesis that the risk of lung cancer from asbestos exposure is confined to persons with radiographic evidence of pulmonary fibrosis. Occupational and smoking histories were obtained from 271 patients with a confirmed diagnosis of primary lung cancer and 678 referents (279 with other respiratory disease and 399 with cardiac disease). Histories were reviewed blind to assess the timing, duration, and probability of exposure to asbestos. To allow for a lag between asbestos exposure and the development of lung cancer, subjects were classified by the time they had spent in an occupation entailing definite or probable exposure more than 15 years before diagnosis. The presence and extent of fibrosis was assessed blindly from chest radiographs by three readers and scored for small opacities with the ILO 1989 International Classification of Radiographs of the Pneumoconioses. 93 (34.3%) cases had worked in an occupation with definite or probable asbestos exposure compared with 176 (25.8%) referents (crude odds ratio for lung cancer 1.49, 95% CI 1.09-2.04). After adjustment for age, sex, smoking history, and area of referral, the odds ratio (95% CI) was 2.03 (1.00-4.13) in the subgroup of 211 with a median ILO score for small parenchymal opacities of 1/0 or more, and 1.56 (1.02-2.39) in the 738 with a score of 0/1 or less (ie, those without radiological evidence of pulmonary fibrosis). These results suggest that asbestos is associated with lung cancer even in the absence of radiologically apparent pulmonary fibrosis.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7715339     DOI: 10.1016/s0140-6736(95)90817-x

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  9 in total

1.  Cyclooxygenase-2 gene and lung carcinoma risk.

Authors:  Ender Coskunpinar; Ilhan Yaylim Eraltan; Akif Turna; Bedia Agachan
Journal:  Med Oncol       Date:  2010-07-20       Impact factor: 3.064

Review 2.  Asbestos, asbestosis, and lung cancer: a critical assessment of the epidemiological evidence.

Authors:  P A Hessel; J F Gamble; J C McDonald
Journal:  Thorax       Date:  2005-05       Impact factor: 9.139

3.  The effect of asbestosis on lung cancer risk beyond the dose related effect of asbestos alone.

Authors:  A Reid; N de Klerk; G L Ambrosini; N Olsen; S C Pang; G Berry; A W Musk
Journal:  Occup Environ Med       Date:  2005-12       Impact factor: 4.402

Review 4.  Asbestos exposure, asbestosis, and asbestos-attributable lung cancer.

Authors:  R N Jones; J M Hughes; H Weill
Journal:  Thorax       Date:  1996-08       Impact factor: 9.139

Review 5.  Systematic review with meta-analysis of the epidemiological evidence in the 1900s relating smoking to lung cancer.

Authors:  Peter N Lee; Barbara A Forey; Katharine J Coombs
Journal:  BMC Cancer       Date:  2012-09-03       Impact factor: 4.430

6.  Exposure to crocidolite and the incidence of different histological types of lung cancer.

Authors:  N H de Klerk; A W Musk; J L Eccles; J Hansen; M S Hobbs
Journal:  Occup Environ Med       Date:  1996-03       Impact factor: 4.402

7.  Asbestos, asbestosis, and lung cancer: observations in Quebec chrysotile workers.

Authors:  B W Case; A Dufresne
Journal:  Environ Health Perspect       Date:  1997-09       Impact factor: 9.031

Review 8.  Asbestos and cancer: An overview of current trends in Europe.

Authors:  M Albin; C Magnani; S Krstev; E Rapiti; I Shefer
Journal:  Environ Health Perspect       Date:  1999-05       Impact factor: 9.031

9.  Review of carcinogenicity of asbestos and proposal of approval standards of an occupational cancer caused by asbestos in Korea.

Authors:  Sanghyuk Im; Kan-Woo Youn; Donghee Shin; Myeoung-Jun Lee; Sang-Jun Choi
Journal:  Ann Occup Environ Med       Date:  2015-12-30
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.